Japan Hospice Holdings Inc. (TYO:7061)
Japan · Delayed Price · Currency is JPY 1,035.00
-20.00 (-1.90%)
Aug 8, 2025, 3:30 PM JST
Blueprint Medicines Revenue
Japan Hospice Holdings had revenue of 3.24B JPY in the quarter ending March 31, 2025, with 18.75% growth. This brings the company's revenue in the last twelve months to 12.63B, up 21.98% year-over-year. In the year 2024, Japan Hospice Holdings had annual revenue of 12.12B with 22.73% growth.
Revenue (ttm)
12.63B
Revenue Growth
+21.98%
P/S Ratio
0.70
Revenue / Employee
11.54M
Employees
1,094
Market Cap
8.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.12B | 2.24B | 22.73% |
| Dec 31, 2023 | 9.87B | 1.98B | 25.04% |
| Dec 31, 2022 | 7.89B | 1.88B | 31.15% |
| Dec 31, 2021 | 6.02B | 1.10B | 22.44% |
| Dec 31, 2020 | 4.92B | 723.00M | 17.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Daiichi Sankyo Company | 1,924.68B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,036.17B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |